OCN SpA has been acquired by ASMAG GmbH
The private equity firm Alcedo SGR SpA has sold its portfolio company OCN SpA to ASMAG GmbH.The sale has been finalized as an asset deal through a procedure and financial details have not been disclosed.
Established in 1977, OCN designs and manufactures systems and equipment for the metallurgical industry. The company was in a difficult financial situation, as a result of two of its main clients going bankrupt.
ASMAG GmbH, based in Scharnstein, Austria, produces equipment for extrusion, pointing, drawing, straightening, cutting and chamfering, finishing, testing, stacking and bundling. A highly qualified engineering team supervises the entire production process and ensures the highest quality control.
Alcedo SGR is an Italian private equity firm investing in small medium-sized companies with a leading position in their respective markets. The firm supports the enterprises and boost their medium and long term growth and development.
Oaklins' team in Italy advised the seller in this transaction.
Talk to the deal team
Related deals
Sunlight Group has acquired a 51% stake in Lehmann Marine GmbH
Through its acquisition of a 51% stake in Lehmann Marine GmbH, Sunlight Group continues to strengthen its position in the growing energy solutions market, while expanding its portfolio of innovative technologies. With over 30 years of expertise in producing lead-acid and lithium-ion batteries, Sunlight Group has established itself as a leader in advanced battery technology.
Learn moreDen Berk Délice accelerates growth through strategic partnership
Den Berk Délice, a leading Belgian grower of specialty tomatoes, has entered a strategic partnership with Egeria, an independent investment firm, to realize its next growth phase.
Learn moreXiel Limited has been acquired by MIS Healthcare
MIS Healthcare, a leading distributor in medical imaging, has successfully acquired Xiel Limited. This strategic acquisition merges MIS Healthcare’s extensive radiotherapy portfolio with Xiel’s specialized expertise in nuclear medicine, radiotherapy and diagnostic radiology. The merger strengthens both companies’ positions in the rapidly growing fields of oncology and nuclear medicine, promising to deliver exceptional value to the healthcare community in the UK and Ireland.
Learn more